(Reuters) - MUMBAI, April 26 - India's Ranbaxy Laboratories Ltd. said on Thursday it had approval from the U.S. Food and Drug Administration to manufacture and market zolpidem tartrate tablets, used to treat insomnia.
The drug, a generic version of Ambien tablets made by France's Sanofi-Aventis , had annual sales of $2.12 billion in the United States, it said.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment